Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether-lumefantrine for uncomplicated falciparum malaria in tribal-dominant states of India
ACTRN12616001478404Phase 4Completed
- Sponsor
- Indian Council of Medical Research
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artemether and lumefantrine in Malaria, sponsored by Indian Council of Medical Research. Primary endpoints: Percentage of treatment failures, Adequate clinical and parasitological response and 1 more. Started Mar 2017; status: completed.
02
Drugs
artemetherlumefantrine
03
Conditions
Malaria
Beyond the preview
Go deeper on ACTRN12616001478404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001478404.